{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T16:05:10Z","timestamp":1772899510349,"version":"3.50.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[1992,9,1]],"date-time":"1992-09-01T00:00:00Z","timestamp":715305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,28]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>A close association has been recognized between activated T cells and eosinophils in asthma, albeit circumstantial. The present study attempted to investigate this relationship in an animal model of lung eosinophilia using the new generation of T cell-selective immunosuppressants, cyclosporin A and FK506, compared with the myelotoxic immunosuppressive agent cyclophosphamide. Antigen challenge of ovalbumin-sensitized guinea-pigs resulted in a lung eosinophilia which was assessed by bronchoalveolar lavage. All three agents caused a marked suppression of lung eosinophilia at 24 h post-challenge when the compounds were administered at the time of sensitization but not when administered for 3 days before lavage. However, the lung eosinophilia at 72 h post-challenge was reduced significantly by FK506 and by cyclophosphamide, but not by cyclosporin A, when the drugs were administered for 3 days, before lavage. These results strongly suggest the involvement of T cells in antigen-induced late phase (72 h) eosinophilia in guinea-pigs but not at 24 h. The effects of cyclophosphamide were always associated with a reduction in circulating white cell counts, whereas cyclosporin A and FK506 showed no myelotoxic properties. These results suggest the potential therapeutic use of selective, non-cytotoxic immunosuppressive agents in asthma.<\/jats:p>","DOI":"10.1111\/j.1365-2249.1992.tb06960.x","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T14:13:00Z","timestamp":1281622380000},"page":"347-350","source":"Crossref","is-referenced-by-count":12,"title":["Protective effects of cyclophosphamide, cyclosporin A and FK506 against antigen-induced lung eosinophilia in guinea-pigs"],"prefix":"10.1093","volume":"89","author":[{"given":"A A","family":"NORRIS","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Fisons plc, Loughborough, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D M","family":"JACKSON","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Fisons plc, Loughborough, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R P","family":"EADY","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Fisons plc, Loughborough, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"2022011618483331200_b1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2222.1989.tb02379.x","article-title":"Basophil mast cell and eosinophil growth and differentiation factors in human allergic disease","volume":"19","author":"Denburg","year":"1989","journal-title":"Clin Exp Allergy"},{"key":"2022011618483331200_b2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.166.1.129","article-title":"Regulation of human eosinophil viability, density, and function by granulocyte\/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts","volume":"168","author":"Owen","year":"1987","journal-title":"J Exp Med"},{"key":"2022011618483331200_b3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1084\/jem.167.1.219","article-title":"Recombinant human IL5 is a selective activator of human eosinophil function","volume":"167","author":"Lopez","year":"1988","journal-title":"J Exp Med"},{"key":"2022011618483331200_b4","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1172\/JCI113547","article-title":"Human eosinophils have prolonged survival, enhanced functional properties and become hypodense when exposed to human interleukin-3","volume":"81","author":"Rothenberg","year":"1988","journal-title":"J Clin Invest"},{"key":"2022011618483331200_b5","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1084\/jem.167.5.1737","article-title":"Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival","volume":"167","author":"Yamaguchi","year":"1988","journal-title":"J Exp Med"},{"key":"2022011618483331200_b6","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(88)91951-4","article-title":"T lymphocyte activation in acute severe asthma","volume":"i","author":"Corrigan","year":"1988","journal-title":"Lancet"},{"key":"2022011618483331200_b7","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1164\/ajrccm\/142.6_Pt_1.1407","article-title":"Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma","volume":"142","author":"Azzawi","year":"1990","journal-title":"Am Rev Resp Dis"},{"key":"2022011618483331200_b8","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1164\/ajrccm\/141.4_Pt_1.","article-title":"T lymphocyte activation in acute severe asthma","volume":"141","author":"Corrigan","year":"1990","journal-title":"Am Rev Resp Dis"},{"key":"2022011618483331200_b9","first-page":"195","volume-title":"Asthma III. Pathophysiology, immunopharmacology and treatment","author":"Gleich","year":"1984"},{"key":"2022011618483331200_b10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2222.1985.tb02290.x","article-title":"Eosinophils, bronchial hyperreactivity and late asthmatic reactions","volume":"15","author":"Durham","year":"1985","journal-title":"Clin Allergy"},{"key":"2022011618483331200_b11","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJM199010113231505","article-title":"Eosinophilic inflammation in asthma","volume":"323","author":"Bousquet","year":"1990","journal-title":"N Engl J Med"},{"key":"2022011618483331200_b12","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.4049\/jimmunol.141.12.4158","article-title":"The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man","volume":"141","author":"Frew","year":"1988","journal-title":"J Immunol"},{"key":"2022011618483331200_b13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1164\/ajrccm\/136.3.600","article-title":"Allergen-induced recruitment of bronchoalveolar helper (OKT4) and suppressor (OKT8) T-cell in asthma","volume":"136","author":"Gonzalez","year":"1987","journal-title":"Am Rev Resp Dis"},{"key":"2022011618483331200_b14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1164\/ajrccm\/141.2.407","article-title":"T lymphocytes and eosinophils in allergen-induced late-phase asthmatic reactions in the guinea-pigs","volume":"141","author":"Frew","year":"1990","journal-title":"Am Rev Resp Dis"},{"key":"2022011618483331200_b15","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1164\/ajrccm\/138.5.1242","article-title":"Evaluation of the in vitro and in vivo effects of cyclosporine on the lung T-lymphocyte alveolitis of active pulmonary sarcoidosis","volume":"138","author":"Martinet","year":"1988","journal-title":"Am Rev Resp Dis"},{"key":"2022011618483331200_b16","first-page":"347","article-title":"Methotrexate in the treatment of steroid-dependent asthma","volume":"56","author":"Mullarkey","year":"1986","journal-title":"Ann Allergy"},{"key":"2022011618483331200_b17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJM198803103181004","article-title":"Methotrexate in the treatment of corticosteroid-dependent asthma","volume":"318","author":"Mullarkey","year":"1988","journal-title":"N Engl J Med"},{"key":"2022011618483331200_b18","first-page":"107","article-title":"Azathioprine treatment of chronic pulmonary sarcoidosis","volume":"8","author":"Pacheco","year":"1985","journal-title":"Sarcoidosis"},{"key":"2022011618483331200_b19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF01973261","article-title":"Biological effects of cyclosporin A: a new anti-lymphocytic agent","volume":"6","author":"Borel","year":"1976","journal-title":"Agents Actions"},{"key":"2022011618483331200_b20","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.7164\/antibiotics.40.1256","article-title":"FK506, a novel immunosuppressant isolated from A. streptomyces. II Immunosuppressant effect of FK506 in vitro","volume":"XL","author":"Kino","year":"1987","journal-title":"J Antibiotics"},{"key":"2022011618483331200_b21","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1164\/ajrccm\/137.3.548","article-title":"Early and late-phase bronchoconstriction after allergen challenge of non-anesthetised guinea-pigs","volume":"137","author":"Hutson","year":"1988","journal-title":"Am Rev Resp Dis"},{"key":"2022011618483331200_b22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2222.1973.tb01321.x","article-title":"Basophils in bronchial asthma with reference to reagin-type allergy","volume":"3","author":"Kimura","year":"1973","journal-title":"Clin Allergy"},{"key":"2022011618483331200_b23","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/ajrccm\/142.3.680","article-title":"Anaphylactic challenge causes eosinophil accumulation in bronchoalveolar lavage fluid of guinea-pigs","volume":"142","author":"Gulbenkian","year":"1990","journal-title":"Am Rev Resp Dis"},{"key":"2022011618483331200_b24","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000235141","article-title":"Human recombinant lymphokines and cytokines induce pulmonary eosinophilia in the guinea-pig which is inhibited by ketotifen and AH 21-132","volume":"91","author":"Kings","year":"1990","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"2022011618483331200_b25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000234790","article-title":"Modulation by drugs of eosinophil recruitment induced by immune challenge in the rat","volume":"88","author":"Etienne","year":"1989","journal-title":"Int Arch All Appl Immunol"},{"key":"2022011618483331200_b26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0006-291X(89)92107-4","article-title":"Effect of cyclosporin A and the platelet-activating factor (PAF) antagonist, BN 52021, on PAF- and antigen-induced bronchoconstriction in the guinea-pig","volume":"163","author":"Touvay","year":"1989","journal-title":"Biochem Biophys Res Comm"},{"key":"2022011618483331200_b27","first-page":"A475","article-title":"Cyclosporin A inhibits allergen-induced late asthmatic response and increase of airway hyperresponsiveness in guinea-pigs","volume":"141","author":"Arima","year":"1990","journal-title":"Am Rev Resp Dis"},{"key":"2022011618483331200_b28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00007890-198902000-00034","article-title":"Effect of a new immunosuppressant agent, FK506, on human lymphocyte responses in vitro: I. FK506 inhibits the expression of alloantigen-activated suppressor cells as well as the induction of alloreactivity","volume":"47","author":"Yoshimura","year":"1989","journal-title":"Transplantation"},{"key":"2022011618483331200_b29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1165\/ajrcmb\/4.3.255","article-title":"Monocyte-macrophage differentiation induced by human upper airway epithelial cells","volume":"4","author":"Ohtoshi","year":"1991","journal-title":"Am J Resp Cell Mol Biol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1992.tb06960.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/89\/3\/347\/42212439\/j.1365-2249.1992.tb06960.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/89\/3\/347\/42212439\/j.1365-2249.1992.tb06960.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:09:45Z","timestamp":1740380985000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/89\/3\/347\/6488098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,9]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,6,28]]},"published-print":{"date-parts":[[2008,6,28]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.1992.tb06960.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1992,9]]},"published":{"date-parts":[[1992,9]]}}}